Also trades as: NRSNW (NASDAQ) · $vol 0M
NRSN NASDAQ
NeuroSense Therapeutics Ltd.
1W: -42.5%
1M: -51.3%
3M: -71.3%
YTD: -74.4%
1Y: -83.9%
3Y: -72.6%
$3.94
-0.12 (-2.84%)
Weekly Expected Move ±25.0%
$2
$3
$4
$5
$6
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$5M
+44.0% ▲
5Y CAGR: +36.8%
Total Liabilities
$2M
-59.7% ▼
5Y CAGR: +121.9%
Shareholders Equity
$3M
+237.8% ▲
5Y CAGR: +23.0%
Cash & Investments
$3M
+28.0% ▲
5Y CAGR: +30.4%
Total Debt
$73K
-48.6% ▼
Net Debt
-$3M
-32.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $699K | $11M | $4M | $3M | $3M |
| Short-Term Investments | $0 | $0 | $4M | $0 | $0 |
| Cash & ST Investments | $699K | $11M | $7M | $3M | $3M |
| Net Receivables | $30K | $178K | $131K | $166K | $164K |
| Inventory | -$67 | -$178K | -$4M | $0 | $0 |
| Other Current Assets | $67 | $217K | $4M | $40K | $35K |
| Total Current Assets | $729K | $11M | $7M | $3M | $4M |
| Property, Plant & Equip. | $13K | $19K | $306K | $238K | $150K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $37K | $0 | $0 | $22K | $23K |
| Other Non-Current Assets | $0 | $0 | $23K | $9K | $0 |
| Total Non-Current Assets | $50K | $19K | $329K | $269K | $173K |
| Total Assets | $779K | $11M | $8M | $3M | $5M |
| — Liabilities — | |||||
| Accounts Payable | $55K | $39K | $498K | $1M | $1M |
| Short-Term Debt | $0 | $0 | $64K | $69K | $73K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $29K | $443K | $349K | $545K | $188K |
| Total Current Liabilities | $120K | $597K | $2M | $3M | $2M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $2M | $218K | $1M | $0 |
| Total Non-Current Liabilities | $0 | $2M | $365K | $2M | $0 |
| Total Liabilities | $120K | $2M | $2M | $5M | $2M |
| — Equity — | |||||
| Common Stock | $1K | $0 | $0 | $0 | $0 |
| Retained Earnings | -$4M | -$8M | -$21M | -$26M | -$37M |
| Accumulated OCI | $0 | $0 | $0 | $24M | $0 |
| Total Stockholders Equity | $659K | $9M | $6M | -$2M | $3M |
| Total Liabilities & Equity | $779K | $11M | $8M | $3M | $5M |
| — Key Metrics — | |||||
| Total Debt | $0 | $2M | $211K | $142K | $73K |
| Net Debt | -$699K | -$9M | -$3M | -$2M | -$3M |
| Total Investments | $37K | $0 | $4M | $22K | $23K |